Watchdog Questions Competition In $45M KPMG COVID Deal
The U.S. Department of Defense may have awarded KPMG LLP a $44.7 million deal to help accelerate access to monoclonal antibody treatments for high-risk COVID-19 patients without putting the professional service...To view the full article, register now.
Already a subscriber? Click here to view full article